(Q39036214)

8 September 2017

title

Survivin gene therapy attenuates left ventricular systolic dysfunction in doxorubicin cardiomyopathy by reducing apoptosis and fibrosis (English)

1 reference

8 September 2017

0 references

1 reference

1 reference

1 reference

7

Howard Leong-Poi

1 reference

8 September 2017

Paul J H Lee

1

1 reference

8 September 2017

Dmitriy Rudenko

2

1 reference

8 September 2017

Michael A Kuliszewski

3

1 reference

8 September 2017

Christine Liao

4

1 reference

8 September 2017

M Golam Kabir

5

1 reference

8 September 2017

Kim A Connelly

6

1 reference

8 September 2017

publication date

8 January 2014

1 reference

8 September 2017

published in

Cardiovascular Research

1 reference

8 September 2017

volume

101

1 reference

8 September 2017

issue

3

1 reference

8 September 2017

page(s)

423-433

1 reference

The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis.

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU001

In search of new therapeutic targets and strategies for heart failure: recent advances in basic science

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU001

Non-cardiomyocyte microRNAs in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU001

Mechanisms of disease: apoptosis in heart failure--seeing hope in death

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU001

Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU001

Beneficial effects of chronic pharmacological manipulation of beta-adrenoreceptor subtype signaling in rodent dilated ischemic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU001

Effects of angiotensin II receptor blocker (candesartan) in daunorubicin-induced cardiomyopathic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU001

Toward antiapoptosis as a new treatment modality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU001

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU001

Survivin determines cardiac function by controlling total cardiomyocyte number

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU001

Myocardial expression of survivin, an apoptosis inhibitor, in aging and heart failure. An experimental study in the spontaneously hypertensive rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU001

Survivin is released from cancer cells via exosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU001

Sustained improvement in perfusion and flow reserve after temporally separated delivery of vascular endothelial growth factor and angiopoietin-1 plasmid deoxyribonucleic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU001

Vascular gene transfer of SDF-1 promotes endothelial progenitor cell engraftment and enhances angiogenesis in ischemic muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU001

Comparison of gene delivery techniques for therapeutic angiogenesis ultrasound-mediated destruction of carrier microbubbles versus direct intramuscular injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU001

Repeated and targeted transfer of angiogenic plasmids into the infarcted rat heart via ultrasound targeted microbubble destruction enhances cardiac repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU001

A mechanistic role for cardiac myocyte apoptosis in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU001

Is survivin the potential Achilles' heel of cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU001

Surviving acute myocardial infarction: survivin expression in viable cardiomyocytes after infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU001

Cardiomyocyte survivin protein expression is associated with cell size and DNA content in the failing human heart and is reversibly regulated after ventricular unloading.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU001

From 'Emax' to pressure-volume relations: a broader view

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU001

Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU001

Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU001

Transplantation with survivin-engineered mesenchymal stem cells results in better prognosis in a rat model of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU001

Survivin's dual role: an export's view

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU001

Nuclear and cytoplasmic survivin: molecular mechanism, prognostic, and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU001

Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU001

Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU001

Optimization of Ultrasound-mediated Anti-angiogenic Cancer Gene Therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU001

Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU001

Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardio

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU001

Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU001

21 January 2018

Identifiers

DOI

10.1093/CVR/CVU001

1 reference

8 September 2017

1 reference